Given the invasiveand cost-intensive nature of tissue biopsies, there is a significant unmet needfor safer and more patient-friendly cancer diagnostics that are capable ofoffering highly accurate, and actionable insights related to the disease.
To order this 350+page report, which features 150+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html
The financial opportunity within the liquid biopsy andother non-invasive cancer diagnostics market has been analyzed across thefollowing segments:
§ Typeof Tumor Marker
- ctDNA
- cfDNA
- CTCs
- Exosomes
- Others
§ Application
- Diagnosis / Early Diagnosis
- Patient Monitoring
- Recurrence Monitoring
§ TargetCancer Indication
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Bladder Cancer
- Melanoma
- Gastric Cancer
- Pancreatic Cancer
- Ovarian Cancer
- Others
§ End Users
- Hospitals
- Research Institutes
- Others
§ Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Rest of the World
The “LiquidBiopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition),2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA,Exosomes and Other Biomarkers.”report features the following companies, which weidentified to be key players in this domain:
§ Amoy Diagnostics
§ DiaCarta
§ HaploX Biotechnology
§ NeoGenomics
§ QIAGEN
§ Swift Biosciences
§ Sysmex Inostics
§ Thermo Fisher Scientific
To request for sample report - https://www.rootsanalysis.com/reports/279/request-sample.html
Table of Contents
1.Preface
2. Executive Summary
3. Introduction
4. Non-InvasiveCancer Screening and Diagnosis
5. MarketLandscape
6.Company Profiles
7.Partnerships and Collaborations
8.Funding and Investment Analysis
9. LiquidBiopsy: Initiatives of Big Pharma Players
10. KeyAcquisition Targets
11.Other Non-Invasive Cancer Diagnostics
12. MarketSizing and Opportunity Analysis
13. SurveyInsights
14.Conclusion
15. ExecutiveInsights
16.Appendix 1: Tabulated Data
17.Appendix 2: List of Companies and Organizations
To purchase a copy,please visit https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html
About Roots Analysis
Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years of significantexperience in this sector. If you’d like help with your growing business needs,get in touch at info@rootsanalysis.com
Other Recent Offerings:
1. Antibody DrugConjugates Market (5th Edition), 2019-2030
2. Gene Therapy Market (3rd Edition), 2019 -2030
3. Global T-Cell (CAR-T,TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030
Contact Information
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter- https://twitter.com/RootsAnalysis
